化合物L-655708
| 中文名稱 | 化合物L-655708 |
|---|---|
| 中文同義詞 | (S)-7-甲氧基-9-氧代-11,12,13,13A-四氫-9H-9H-咪唑并[1,5-A]吡咯并[2,1-C][1,4]苯二氮-1-羧酸乙酯;化合物L-655708;L-655,708,苯二氮卓類反向激動劑;(S)-7-甲氧基-9-氧代-11,12,13,13A-四氫-9H-苯并[E]咪唑并[5,1-C]吡咯并[1,2-A][1,4]二氮雜卓-1-羧酸乙酯;化合物L-655708,10 MM DMSO 溶液;L-655708試劑;L-655708試劑 |
| 英文名稱 | L-655,708 |
| 英文同義詞 | 9H-IMidazo[1,5-a]pyrrolo[2,1-c][1,4]benzodiazepine-1-carboxylic acid, 11,12,13,13a-tetrahydro-7-Methoxy-9-oxo-, ethyl ester, (13aS)-;9H-IMidazo[1,5-a]pyrrolo[2,1-c][1,4]benzodiazepine-1-carboxylic acid, 11,12,13,13a-tetrahydro-7-Methoxy-9-oxo-, ethyl ester, (13aS)- (011-14426_500Mg);Ethyl (S)-11,12,13,13a-Tetrahydro-7-methoxy-9-oxo-9H-imidazo[1,5-a]pyrrolo[2,1-c][1,4]benzodiazepine-1-carboxylate;11,12,13,13a-Tetrahydro-7-methoxy-9-oxo-9H-imidazo[1.5-a]pyrrolo[2.1-c][1.4]benzodiazepine-1-carboxylicacidethylester;11,12,13,13A-TETRAHYDRO-7-METHOXY-9-OXO-9H-IMIDAZO[1,5-A]PYRROLO[2,1-C][1,4]BENZODIAZEPINE-1-CARBOXYLIC ACID, ETHYL ESTER;L-655,708;ETHYL (S)-11,12,13,13A-TETRAHYDRO-7-METHOXY-9-OXO-9H-IMIDAZO[1,5-A]PYRROLO[2,1-C][1,4]BENZODIAZEPINE-1-CARBOXYLATE;(S)-ethyl 7-methoxy-9-oxo-11,12,13,13a- tetrahydro-9H-benzo[e]imidazo[5,1-c]pyrrolo[1,2-a][1,4]diazepine-1-carboxylate |
| CAS號 | 130477-52-0 |
| 分子式 | C18H19N3O4 |
| 分子量 | 341.36 |
| EINECS號 | |
| 相關(guān)類別 | GABA/Glycine receptor |
| Mol文件 | 130477-52-0.mol |
| 結(jié)構(gòu)式 |  |
化合物L-655708 性質(zhì)
| 熔點 | 175-176 °C |
|---|---|
| 沸點 | 584.4±50.0 °C(Predicted) |
| 密度 | 1.42±0.1 g/cm3(Predicted) |
| 儲存條件 | Desiccate at +4°C |
| 溶解度 | 二甲基亞砜：6 mg/毫升 |
| 形態(tài) | 粉末 |
| 酸度系數(shù)(pKa) | 1.49±0.20(Predicted) |
| 顏色 | 白色至黃色 |
| InChI | 1S/C18H19N3O4/c1-3-25-18(23)15-16-14-5-4-8-20(14)17(22)12-9-11(24-2)6-7-13(12)21(16)10-19-15/h6-7,9-10,14H,3-5,8H2,1-2H3/t14-/m0/s1 |
| InChIKey | YKYOQIXTECBVBB-AWEZNQCLSA-N |
| SMILES | CCOC(=O)c1ncn2-c3ccc(OC)cc3C(=O)N4CCCC4c12 |
L-655708 是有效的, 選擇性 GABAA 受體反向激動劑 (Ki=0.45 nM)。
L655708 is a potent, selective inverse agonist for the benzodiazepine site of GABAA receptors containing the α5 subunit (Ki = 0.45 nM). Displays 50-100-fold selectivity over GABAA receptors containing α1, α2, α3 orα6 subunits in combination with β3 and γ2. Enhances LTP in a mouse hippocampal slice model and increases spatial learning, without displaying proconvulsant activity.
L-655708 at 0.7 mg/kg, administered intraperitoneally, would result in 60-70% occupancy of α5 GABAA receptors with limited binding to α1, α2, and α3 subunit-containing GABAA receptors and no significant off-target behavioral effects, such as sedation and motor impairment.
安全信息
| WGK Germany | 3 |
|---|---|
| 存儲類別 | 11 - 可燃固體 |
| 提供商 | 語言 |
|---|---|
|
英文
|
| 更新日期 | 產(chǎn)品編號 | 產(chǎn)品名稱 | CAS號 | 包裝 | 價格 |
|---|---|---|---|---|---|
| 2026/06/05 | HY-14426 | 130477-52-0 L-655708 | 130477-52-0 | 5mg | 880元 |
| 2026/06/05 | HY-14426 | 130477-52-0 L-655708 | 130477-52-0 | 10mM * 1mLin DMSO | 968元 |